BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36259160)

  • 41. Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model.
    Villard C; Abdelrafee A; Habib M; Ndegwa N; Jorns C; Sparrelid E; Allard MA; Adam R
    Eur J Surg Oncol; 2022 Dec; 48(12):2432-2439. PubMed ID: 35786533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study.
    Deng Y; Chen Q; Chen J; Zhang Y; Zhao J; Bi X; Li Z; Zhang Y; Huang Z; Cai J; Zhao H
    BMC Surg; 2023 May; 23(1):131. PubMed ID: 37194000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Safety and Survival Outcome of Hepatectomy with Combined Bile Duct Resection for Colorectal Liver Metastasis.
    Ito T; Sugiura T; Okamura Y; Yamamoto Y; Ashida R; Ohgi K; Yasui H; Yamazaki K; Uesaka K
    World J Surg; 2020 Apr; 44(4):1231-1243. PubMed ID: 31832703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
    Sasaki K; Andreatos N; Margonis GA; He J; Weiss M; Johnston F; Wolfgang C; Antoniou E; Pikoulis E; Pawlik TM
    J Surg Oncol; 2016 Dec; 114(7):803-809. PubMed ID: 27792291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysis.
    Zhao J; Zhu J; Sun R; Huang C; Yuan R; Zhu Z
    BMC Cancer; 2021 May; 21(1):503. PubMed ID: 33957871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term outcome and quality of life after initial and repeat resection of colorectal liver metastasis: A retrospective analysis.
    Heise D; Bayings W; Tuinhof A; Eickhoff R; Kroh A; Ulmer F; Dejong CHC; Neumann U; Binnebösel M
    Int J Surg; 2017 Dec; 48():281-285. PubMed ID: 29175019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases.
    Yoshimoto T; Morine Y; Imura S; Ikemoto T; Iwahashi S; Saito YU; Yamada S; Ishikawa D; Teraoku H; Yoshikawa M; Higashijima J; Takasu C; Shimada M
    In Vivo; 2017; 31(3):419-423. PubMed ID: 28438872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of
    Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
    Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic impact of additive chemotherapy after curative resection of metachronous colorectal liver metastasis: a single-centre retrospective study.
    Kelm M; Schollbach J; Anger F; Wiegering A; Klein I; Germer CT; Schlegel N; Kunzmann V; Löb S
    BMC Cancer; 2021 May; 21(1):490. PubMed ID: 33941104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimal cut-off value for the number of colorectal liver metastases: a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Beppu T; Sakamoto Y; Hasegawa K; Honda G; Tanaka K; Kotera Y; Nitta H; Yoshidome H; Hatano E; Ueno M; Takamura H; Baba H; Kosuge T; Kokudo N; Takahashi K; Endo I; Wakabayashi G; Miyazaki M; Uemoto S; Ohta T; Kikuchi K; Takayama T; Yamaue H; Yamamoto M; Takada T
    J Hepatobiliary Pancreat Sci; 2014 Mar; 21(3):169-75. PubMed ID: 24307562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrence patterns after laparoscopic resection of colorectal liver metastases.
    Tabchouri N; Gayet B; Okumura S; Donatelli G; Beaussier M; Bennamoun M; Louvet C; Fuks D
    Surg Endosc; 2018 Dec; 32(12):4788-4797. PubMed ID: 29761279
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short- and long-term outcomes of surgery for colorectal and non-colorectal liver metastasis: a report from a single center in the Baltic country.
    Račkauskas R; Baušys A; Sokolovas V; Paškonis M; Strupas K
    World J Surg Oncol; 2020 Jul; 18(1):164. PubMed ID: 32664960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.
    Andreatos N; Ronnekleiv-Kelly S; Margonis GA; Sasaki K; Gani F; Amini N; Wilson A; Pawlik TM
    Surg Oncol; 2016 Sep; 25(3):332-8. PubMed ID: 27566041
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Size of the Largest Colorectal Liver Metastasis Is an Independent Prognostic Factor in the Neoadjuvant Setting.
    Ren W; Sell NM; Ferrone CR; Tanabe KK; Lillemoe KD; Qadan M
    J Surg Res; 2021 Mar; 259():253-260. PubMed ID: 33160635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prognostic factors of patients with unresectable liver metastasis from colorectal cancer after failed conversion chemotherapy].
    He H; Shen W; Chen W; Liu H; Gong W; Fu J; Hu X; Cui L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1261-1267. PubMed ID: 30506537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Impact of Budding Grade in Patients With Residual Liver Recurrence of Colorectal Cancer After Initial Hepatectomy.
    Noro T; Nishikawa M; Hoshikawa M; Einama T; Aosasa S; Kajiwara Y; Yaguchi Y; Okamoto K; Shinto E; Tsujimoto H; Hase K; Ueno H; Yamamoto J
    Ann Surg Oncol; 2020 Dec; 27(13):5200-5207. PubMed ID: 32488517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of genomic profiles and survival in early onset and screening-age colorectal cancer patients with liver metastases resected over 15 years.
    Narayan RR; Aveson VG; Chou JF; Walch HS; Sanchez-Vega F; Santos Fernandes GD; Balachandran VP; D'Angelica MI; Drebin JA; Jarnagin WR; Wei AC; Cercek A; Gönen M; Schultz N; Kingham TP
    J Surg Oncol; 2022 Apr; 125(5):880-888. PubMed ID: 35066881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
    Margonis GA; Buettner S; Andreatos N; Sasaki K; Ijzermans JNM; van Vugt JLA; Pawlik TM; Choti MA; Cameron JL; He J; Wolfgang CL; Weiss MJ
    Ann Surg; 2017 Oct; 266(4):641-649. PubMed ID: 28657938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study.
    Beppu T; Wakabayashi G; Hasegawa K; Gotohda N; Mizuguchi T; Takahashi Y; Hirokawa F; Taniai N; Watanabe M; Katou M; Nagano H; Honda G; Baba H; Kokudo N; Konishi M; Hirata K; Yamamoto M; Uchiyama K; Uchida E; Kusachi S; Kubota K; Mori M; Takahashi K; Kikuchi K; Miyata H; Takahara T; Nakamura M; Kaneko H; Yamaue H; Miyazaki M; Takada T
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):711-20. PubMed ID: 25902703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.